Skip to main content
. 2013 Jun 10;8(6):e65114. doi: 10.1371/journal.pone.0065114

Figure 3. CEC modification during worsening in patients treated with SC treprostinil.

Figure 3

A- Time course of CEC counts in a patient with stable iPAH under treatment. B- Time course of CEC counts in a patient with PAH-CHD with a small VSD (subtype 1C Dana-Point classification of CHD-PAH). C- Time course of CEC counts in a patient with iPAH.